DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20160286

Impact of factors at admittance predicting intensive care unit mortality in critically ill cancer patients

Yusuf Savran, Rukiye Arikan, Bilgin Comert

Abstract


Background: The aim of this study is to evaluate the prognostic factors at medical ICU admittance predicting intensive care unit (ICU) mortality in cancer patients.

Methods: Retrospectively data of adult patients admitted to medical ICU of a 1200-bed university hospital during January 2012-December 2013 interval were analysed. The patients were divided into three groups; patients with solid tumor, patients with hematologic malignancy and patients without cancer. The study end point was ICU mortality.

Results: 512 patients were identified; 374 patients without cancer, 89 patients with solid tumor and 49 patients with hematologic malignancy. Overall mortality rate in intensive care unit was 46% (n=236). The ICU mortality rate of patients with hematologic malignancy was significantly higher than patients with solid tumors (68.6% vs 53%; p<0.001) and patients without cancer (68.6% vs 39.8%; p<0.001). Logistic regression analysis showed high APACHE II score and the requirement for invasive mechanical ventilation (odds ratio [OR], 5.52; 95% confidence interval [CI], 2.10-14.53; p<0.001) at the time of intensive care unit admittance as independent risk factors for increased mortality. In addition, the requirement of renal replacement therapy(OR, 2.34; [CI: 1.44-3.80]; p<0.002) and vasopressors(OR, 1.67; [CI: 1.10-2.54]; p<0.02)  at the time of intensive care unit admittance were detected as independent risk factors for increased mortality in cancer free group.

Conclusions: In critically ill cancer patients; high APACHE II score and the requirement of invasive mechanical ventilation should be evaluated at the time of intensive care unit admittance, for these are strong predictors of increased mortality.


Keywords


Malignancy, Cancer, Critical care, Critically ill, Mortality

Full Text:

PDF

References


Shelton BK. Critical care of cancer patients: past, present and future. Semin Oncol Nurs. 1994;10(3):146-55.

Groeger JS, Aurora RN. Intensive care, mechanical ventilation, dialysis, and cardiopulmonary resuscitation. Implications for the patient with cancer. Crit Care Clin. 2001;17(3):991-7.

Brenner H. Long-term survival rates for cancer patients achieved by the end of the 20th century: a period analysis. Lancet. 2002;360(9340):1131-5.

Azoulay E, Recher C, Alberti C, Soufir L, Leleu G, Le Gall JR. Intensive Care Med. Changing use of intensive care for hematological patients: the example of multiple myeloma. 1999;25(12):1395-401.

Raoof ND, Groeger JS. You never know–one of your patients with cancer might surprise you. Crit Care Med. 2007;35(3):965-6.

Staudinger T, Stoiser B, Maxllner M, Locker GJ, Laczika K, Knapp S. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med. 2000;28(5):1322-8.

Moran JL, Soloman PJ, Williams PJ. Assessment of outcome over a 10-year period of patients admitted to a multidisciplinary adult intensive care unit with haematological and solid tumors. Anaesth Intensive Care. 2005;33(1):26-35.

Van Gestel JP, Bollen CW, Van der Tweel I, Boelens JJ, Van Vught AJ. Intensive care unit mortality trends in children after hematopoietic stem cell transplantation: a meta-regression analysis. Crit Care Med. 2008;36:2898.

Soares M, Caruso P, Silva E, Teles JM, Lobo SM, Friedman G. Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med. 2010;38:9

Azoulay E, Mokart D, Pène F, Lambert J, Kouatchet A, Mayaux J. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol. 2013;31(22):2810-8.

Vandijck DM, Benoit DD, Depuydt PO, Offner FC, Blot SI, Van Tilborgh AK. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med. 2008;34:847.

Estopa R, Torres Marti A, Kastanos N, Rives A, Agusti-Vidal A, Rozman C. Acute respiratory failure in severe hematologic disorders. Crit Care Med. 1984;12:26-8.

Bird GT, Farquhar-Smith P, Wigmore T, Potter M, Gruber PC. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br. J. Anaesth. 2012;108(3):452-9.

Parakh S, Piggin A, Neeman T, Mitchell I, Crispin P, Davis A. Outcomes of haematology/oncology patients admitted to intensive care unit at The Canberra Hospital. Intern Med J. 2014;44(11):1087-94.

Puxty K, McLoone P, Quasim T, Kinsella J, Morrison D. Survival in solid cancer patients following intensive care unit admission. Intensive Care Med. 2014;40(10):1409-28.

Kress JP, Christenson J, Pohlman AS, Linkin DR, Hall JB. Out-comes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med. 1999;160(6):1957-61.

Soares M, Salluh JI, Spector N, Rocco JR. Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 hrs. Crit Care Med. 2005;33(3):520-6.

Darmon M, Azoulay E, Alberti C, Fieux F, Moreau D, Le Gall. Impact of neutropenia duration on short-term mortalityin neutropenic critically ill cancer patients. Intensive Care Med. 2002;28(12):1775-80.

Khassawneh BY, White P, Anaissie AJ, Barlogie B, Hiller FC. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest. 2002;121(1):185-8.

Libório AB, Abreu KL, Silva GB, Lima RS, Barreto AG, Barbosa OA. Predicting hospital mortality in critically ill cancer patients according to acute kidney injury severity. Oncology. 2011;80(3-4):160-6.

Aygencel G, Turkoglu M, Turkoz Sucak G, Benekli M. Prognostic factors in critically ill cancer patients admitted to the intensive care unit. J Crit Care. 2014;29(4):618-26.

Andrejak C, Terzi N, Thielen S, Bergot E, Zalcman G, Charbonneau P. Admission of advanced lung cancer patients to intensive care unit: a retrospective study of 76 patients. BMC Cancer. 2011;11:159.

Song JU, Suh GY, Chung MP, Kim H, Kwon OJ, Jung CW et al. Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit. Support Care Cancer. 2011 Apr;19(4):491-5.

Zuber B, Tran TC, Aegerter P, Grimaldi D, Charpentier J, Guidet B, et al. Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med. 2012 Jan;40(1):55-62

Namendys-Silva SA, Texcocano-Becerra J, Herrera-Gómez A. Prognostic factors in critically ill patients with solid tumours admitted to an oncological intensive care unit. Anaesth Intensive Care. 2010;38(2):317-24.

Taccone FS, Artigas AA, Sprung CL, Moreno R, Sakr Y, Vincent JL. Characteristics and outcomes of cancer patients in European ICUs. Crit Care. 2009;13(1):R15.

Saillard C, Mokart D, Lemiale V, Azoulay E. Mechanical ventilation in cancer patients. Minerva Anestesiol. 2014;80(6):712-25.

Park SY, Lim SY, Um SW, Koh WJ, Chung MP, Kim H. Outcome and predictors of mortality in patients requiring invasive mechanical ventilation due to acute respiratory failure while undergoing ambulatory chemotherapy for solid cancers. Support Care Cancer. 2013;21(6):1647-53.

Heo SJ, Kim G, Lee CK, Chung KS, Choi HJ, Sohn J. Prediction of short-and long-term survival for advanced cancer patients after ICU admission. Support Care Cancer. 2015;23(6):1647-55.

Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S. Acute renal failure in critically ill patients. JAMA. 2005;294(7):813-8.

Hill QA, Kelly RJ, Patalappa C, Whittle AM, Scally AJ, Hughes A. Survival of patients with hematological malignancy admitted to the intensive care unit: prognostic factors and outcome compared to unselected medical intensive care unit admissions, a parallel group study. Leuk Lymphoma. 2012;53(2):282-8.

Mokart D, Etienne A, Esterni B, Brun JP, Chow-Chine L, Sannini A. Critically ill cancer patients in the intensive care unit: short-term outcome and 1-year mortality. Acta Anaesthesiol Scand. 2012;56(2):178-89.

Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303-10.

Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med. 1985;13(10):818-29.

Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc. 1992;67(2):117-22.

Paz HL, Crilley P, Weinar M, Brodsky I. Outcome of patients requiring medical ICU admission following bone marrow transplantation. Chest. 1993;104(2):527-31.

Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.

Mokart D, Azoulay E, Schnell D, Bourmaud A, Kouatchet A, Pène F. Acute respiratory failure in neutropenic patients is associated with a high post- ICU mortality. Minerva Anestesiol. 2013;79(10):1156-63.